News

From hand sanitizer use to monitoring chronic conditions, hospitals can find novel ways to harness the power of AI, according to a new report.

Why the website’s banking on crowdsourced trial predictions, data visualizations, and community.

"They’re actually, in my opinion, driving people from the best doctors to the nicest doctors. Is there value in that?"

Qiagen and Centogene AG hope to use sprawling data sets and AI to improve clinical prediction.

Less than 30 percent of hospitals got where they needed to be in 2015. But why?

A doctor and CEO explains how telemedicine can improve hospital care as the number of non-physician clinicians rises.

Lessons from GlaxoSmithKline’s app-based study can benefit healthcare companies.

After hitting 3 key goals, GlaxoSmithKline’s PARADE could help change data collection.

What needs to happen before Alexa answers questions about your meds?

Risk is inherent, one Takeda exec said. But the potential is clear.

The buyer touted the lab company's "unique epigenetic technology and expertise."

Takeda Pharmaceuticals uses this rubric to know what it’s getting into. You can, too.

They waste time and money. Can electronic health records help?

And what healthcare executives and innovators can learn from its launch.

McClellan will be joined by a roster of other healthcare industry veterans and experts.

A Mayo Clinic physician and engineer, Jean Huddleston, MD, describes how healthcare companies can benefit from multidisciplinary “translators.”

The method pushed people to exercise more often, a new study found.

How data could spur cost savings in treating a disease that's expected to cost $14.7B per year.

The acclaimed author of The Innovator's Dilemma explained to hospital leaders what they need to do to disrupt rather than just sustain.

In a panel at the Mayo Clinic Center for Innovation's Transform conference, healthcare leaders went so far as to call current systems "crude" and "corrosive."

The National Institutes of Health says it’s one of the largest data sets ever made public.

Burnout is a problem. This medical school dean says innovation and good old-fashioned empathy can help.

As participants like Apple and Samsung prepare to huddle, Pear Therapeutics sees the upside.

The man who ran Medicare and Medicaid under President Obama speaks out.

Curtis Hanson, MD, sat down to discuss the role of laboratory testing in the pursuit of value-based care.

And what can physicians learn from data linked to questionably prescribed pain meds?

The company’s largest round of funding underscores the strength of a device and an algorithm.

How data led to a discovery that could accelerate the development of new drugs.